These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20661738)

  • 1. Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity.
    Rodríguez-Rodríguez L; Lamas JR; Varadé J; López-Romero P; Tornero-Esteban P; Abasolo L; de la Concha EG; Jover JA; Urcelay E; Fernández-Gutiérrez B
    Rheumatol Int; 2011 Mar; 31(3):409-13. PubMed ID: 20661738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.
    Lamas JR; Rodríguez-Rodríguez L; Tornero-Esteban P; Villafuertes E; Hoyas J; Abasolo L; Varadé J; Alvarez-Lafuente R; Urcelay E; Fernández-Gutiérrez B
    Cytokine; 2013 Mar; 61(3):720-3. PubMed ID: 23375120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility.
    Marinou I; Walters K; Winfield J; Bax DE; Wilson AG
    Ann Rheum Dis; 2010 Jun; 69(6):1191-4. PubMed ID: 19713205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis.
    Lamas JR; Rodríguez-Rodríguez L; Varadé J; López-Romero P; Tornero-Esteban P; Abasolo L; Urcelay E; Fernández-Gutiérrez B
    J Rheumatol; 2010 Aug; 37(8):1579-81. PubMed ID: 20551110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.
    Hassan B; Maxwell JR; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG
    Rheumatology (Oxford); 2010 Jan; 49(1):43-7. PubMed ID: 19926672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis.
    Polgár A; Brózik M; Tóth S; Holub M; Hegyi K; Kádár A; Hodinka L; Falus A
    Med Sci Monit; 2000; 6(1):13-8. PubMed ID: 11208277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.
    Diaz-Torne C; Ortiz MDA; Moya P; Hernandez MV; Reina D; Castellvi I; De Agustin JJ; Fuente D; Corominas H; Sanmarti R; Zamora C; Cantó E; Vidal S
    Semin Arthritis Rheum; 2018 Jun; 47(6):757-764. PubMed ID: 29157669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.
    Galicia JC; Tai H; Komatsu Y; Shimada Y; Akazawa K; Yoshie H
    Genes Immun; 2004 Sep; 5(6):513-6. PubMed ID: 15306846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis.
    Fabris M; Quartuccio L; Lombardi S; Saracco M; Atzeni F; Carletto A; Cimmino M; Fabro C; Pontarini E; Pellerito R; Bambara LM; Sarzi-Puttini P; Cutolo M; Manfredi M; Benucci M; Morassi P; Fischetti F; Padovan M; Govoni M; Curcio F; Tonutti E; De Vita S
    Autoimmun Rev; 2012 Mar; 11(5):315-20. PubMed ID: 20974296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis.
    Xu H; Liu J; Niu M; Song S; Wei L; Chen G; Ding Y; Wang Y; Su Z; Wang H
    J Mol Med (Berl); 2021 Jul; 99(7):1009-1020. PubMed ID: 33835216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects.
    Rafiq S; Frayling TM; Murray A; Hurst A; Stevens K; Weedon MN; Henley W; Ferrucci L; Bandinelli S; Corsi AM; Guralnik JM; Melzer D
    Genes Immun; 2007 Oct; 8(7):552-9. PubMed ID: 17671508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
    Horiuchi S; Ampofo W; Koyanagi Y; Yamashita A; Waki M; Matsumoto A; Yamamoto M; Yamamoto N
    Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
    Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.
    Nishimoto N; Terao K; Mima T; Nakahara H; Takagi N; Kakehi T
    Blood; 2008 Nov; 112(10):3959-64. PubMed ID: 18784373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of the functional IL6R polymorphism rs2228145, eQTLs and other genome-wide SNPs to the heritability of plasma sIL-6R levels.
    van Dongen J; Jansen R; Smit D; Hottenga JJ; Mbarek H; Willemsen G; Kluft C; ; Penninx BW; Ferreira MA; Boomsma DI; de Geus EJ
    Behav Genet; 2014 Jul; 44(4):368-82. PubMed ID: 24791950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.